Works matching IS 19466234 AND DT 2018 AND VI 10 AND IP 463

Results: 5

Health and societal implications of medical and technological advances.
Published in:
Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aau4778
By:
- Dzau, Victor J.;
- Balatbat, Celynne A.
Publication type:
Article
In utero priming of highly functional effector T cell responses to human malaria.
Published in:
Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aat6176
By:
- Odorizzi, Pamela M.;
- Jagannathan, Prasanna;
- McIntyre, Tara I.;
- Budker, Rachel;
- Prahl, Mary;
- Auma, Ann;
- Burt, Trevor D.;
- Nankya, Felistas;
- Nalubega, Mayimuna;
- Sikyomu, Esther;
- Musinguzi, Kenneth;
- Naluwu, Kate;
- Kakuru, Abel;
- Dorsey, Grant;
- Kamya, Moses R.;
- Feeney, Margaret E.
Publication type:
Article
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
Published in:
Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aat5775
By:
- Slaga, Dionysos;
- Ellerman, Diego;
- Lombana, T. Noelle;
- Vij, Rajesh;
- Li, Ji;
- Hristopoulos, Maria;
- Clark, Robyn;
- Johnston, Jennifer;
- Shelton, Amy;
- Mai, Elaine;
- Gadkar, Kapil;
- Lo, Amy A.;
- Koerber, James T.;
- Totpal, Klara;
- Prell, Rodney;
- Lee, Genee;
- Spiess, Christoph;
- Junttila, Teemu T.
Publication type:
Article
A dysbiotic microbiome triggers T<sub>H</sub>17 cells to mediate oral mucosal immunopathology in mice and humans.
Published in:
Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aat0797
By:
- Dutzan, Nicolas;
- Kajikawa, Tetsuhiro;
- Abusleme, Loreto;
- Greenwell-Wild, Teresa;
- Zuazo, Carlos E.;
- Ikeuchi, Tomoko;
- Brenchley, Laurie;
- Abe, Toshiharu;
- Hurabielle, Charlotte;
- Martin, Daniel;
- Morell, Robert J.;
- Freeman, Alexandra F.;
- Lazarevic, Vanja;
- Trinchieri, Giorgio;
- Diaz, Patricia I.;
- Holland, Steven M.;
- Belkaid, Yasmine;
- Hajishengallis, George;
- Moutsopoulos, Niki M.
Publication type:
Article
Mixed-effects association of single cells identifies an expanded effector CD4<sup>+</sup> T cell subset in rheumatoid arthritis.
Published in:
Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aaq0305
By:
- Fonseka, Chamith Y.;
- Rao, Deepak A.;
- Teslovich, Nikola C.;
- Korsunsky, Ilya;
- Hannes, Susan K.;
- Slowikowski, Kamil;
- Gurish, Michael F.;
- Donlin, Laura T.;
- Lederer, James A.;
- Weinblatt, Michael E.;
- Massarotti, Elena M.;
- Coblyn, Jonathan S.;
- Helfgott, Simon M.;
- Todd, Derrick J.;
- Bykerk, Vivian P.;
- Karlson, Elizabeth W.;
- Ermann, Joerg;
- Lee, Yvonne C.;
- Brenner, Michael B.;
- Raychaudhuri, Soumya
Publication type:
Article

Works matching IS 19466234 AND DT 2018 AND VI 10 AND IP 463

Health and societal implications of medical and technological advances.

In utero priming of highly functional effector T cell responses to human malaria.

Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.

A dysbiotic microbiome triggers T<sub>H</sub>17 cells to mediate oral mucosal immunopathology in mice and humans.

Mixed-effects association of single cells identifies an expanded effector CD4<sup>+</sup> T cell subset in rheumatoid arthritis.